| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.015 | 0.8 |